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Abstract
Introduction: In recent years, positron emission tomography (PET) has been increasingly applied in the diagnosis of neoplastic 
lung diseases. In contrast to conventional imaging studies, PET-CT enables the visualisation of not only the morphology of the 
suspicious lesion, but also its metabolism. The aim of the present study was to investigate the role of PET-CT in the initial assess-
ment of patients with indeterminate solitary pulmonary lesions.
Material and methods: The study was conducted on a group of 82 patients with indeterminate lung nodule diagnosed at the Na-
tional Institute of Tuberculosis and Lung Diseases in the period from January 2008 to May 2011. CT and PET-CT were performed in 
all of the patients. Histological or cytological examination of the biopsy specimens obtained from bronchoscopy, mediastinoscopy 
and intraoperatively were the reference tests. 
Results: Malignancy was documented in 40 patients (48.8%). Histopathological analysis of all tumours revealed 12 cases of squa-
mous cell carcinoma, 18 cases of adenocarcinoma and 1 case of carcinoid, whereas in 9 patients the diagnosis of “non-small cell 
cancer not otherwise specified” was made. All lesions except one were of solid character on chest CT. SUVmax values exceeding 
2.5 were found in 38 cancer patients (true positives, TP). The mean value of SUVmax was 9.1 (1–26.8).
Forty-two lesions were documented as benign (51.2%). SUVmax values equal to or less than 2.5 were found in 37 patients (true 
negatives, TN). The mean value of SUVmax in this group was 1.9 (0.5–8.6). The diagnostic value of PET-CT SUVmax exceeding 2.5 
in the prediction of neoplastic origin of solitary pulmonary lesions was: sensitivity — 95% (95% CI 84–99%), specificity — 88% 
(95% CI 75–95%) and accuracy — 91.5% (95% CI 83–96%). Positive predictive value (PPV) was 88.4% (95% CI 76–95%), and 
negative predictive value (NPV) was 94.8% (95% CI 83–99%). False negative results concerned two patients, with final diagnosis 
of carcinoid and adenocarcinoma; false positive results were obtained in 5 patients with various inflammatory lesions. 
Conclusions: In the present study, PET-CT appeared to have high sensitivity (95%), but lower specificity (88%) for predicting the 
malignant character of solitary pulmonary lesions. Overall diagnostic value of PET-CT SUVmax > 2.5 was high — PPV was 88.4%, 
NPV was 94.8%. 
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In the authors’ opinion, the PET-CT value may increase when clinical data as well as other radiological documentation (with 
retrospective assessment) are taken into consideration.
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Streszczenie
Wstęp: W ostatnich latach w diagnostyce raka płuca coraz szersze zastosowanie znajduje pozytonowa tomografia emisyjna 
(PET). W odróżnieniu od klasycznych metod obrazowania PET-CT daje możliwość uwidocznienia nie tylko morfologii, ale także 
metabolizmu podejrzanego ogniska. Celem pracy była ocena przydatności metody PET-CT w ocenie charakteru zmiany ogniskowej 
w płucu.
Materiał i metody: Badanie przeprowadzono w grupie 82 pacjentów diagnozowanych w Instytucie Gruźlicy i Chorób Płuc pod 
kątem oceny charakteru zmiany ogniskowej w płucu w okresie od stycznia 2008 roku do maja 2011 roku. U wszystkich chorych 
wykonywano badania CT i PET-CT. Testem referencyjnym było badanie histologiczne lub cytologiczne materiału uzyskanego 
z bronchoskopii, mediastinoskopii oraz śródoperacyjnie.
Wyniki: Obecność raka płuca potwierdzono u 40 pacjentów (48,8%). Wśród zmian złośliwych 12 miało charakter raka płaskon-
abłonkowego, 18 odpowiadało gruczolakorakowi, jedna zmiana okazała się rakowiakiem, a 9 z nich miało charakter raka niedrob-
nokomórkowego bez określenia podtypu. Wszystkie guzki, poza jednym miały charakter lity. U 38 chorych w tej grupie wartości 
SUVmax przekraczały 2,5 (wyniki prawdziwie pozytywne). Średnia wartość SUVmax wynosiła 9,1 (1–26,8).
Zmiany łagodne potwierdzono u 42 pacjentów (51,2%). U 37 chorych SUVmax był niższy lub równy 2,5. Średnia spośród podanych 
wartości SUVmax dla zmian łagodnych wynosiła 1,9 (0,5–8,6).
Wartość diagnostyczna SUVmax powyżej 2,5 w PET-CT dla oceny nowotworowego charakteru zmiany ogniskowej w badanej grupie 
chorych była następująca: czułość testu — 95% (95% CI 84–99%), swoistość — 88%, (95% CI 75–95%), dokładność — 91,5% 
(95% CI 83–96%). Wartość predykcyjna wyniku dodatniego (PPV) wynosiła 88,4% (95% CI 76–95%), wartość predykcyjna wyn-
iku ujemnego (NPV) — 94,8% (95% CI 83–99%). U dwóch chorych z ostatecznym rozpoznaniem: rakowiaka oraz gruczolakoraka 
wykazano fałszywie ujemny wynik badania PET-CT ( SUVmax < 2,5). U pięciu chorych z guzkami o etiologii zapalnej stwierdzono 
fałszywie dodatni wynik PET-CT.
Wnioski: W badanym materiale stwierdzono wysoką czułość (95%) i nieco niższą swoistość (88%) badania PET-CT w prog-
nozowaniu nowotworowego charakteru pojedynczych zmian ogniskowych w płucu. Ogólna wartość diagnostyczna PET-CT 
w różnicowaniu zmian ogniskowych w płucach była wysoka: wartość predykcyjna wyniku dodatniego (PPV) wynosiła 88,4%, war-
tość predykcyjna wyniku ujemnego (NPV) — 94,8%. W opinii autorów, szczególnie istotne jest, aby przy analizie badania PET-CT 
brać pod uwagę w ocenie zmiany również dane kliniczne i wyniki różnych badań obrazowych (wraz z ich oceną retrospektywną). 
Słowa kluczowe: pojedynczy guzek płuca, rak płuca, PET-CT, fluorodeoksyglukoza
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Introduction
Positron emission tomography has been used 
with increasing frequency in the diagnosis of lung 
cancer during recent years. It plays a crucial role 
in differentiating between benign and malignant 
pulmonary lesions. Contrary to classical methods 
of imaging, a PET-CT scan shows not only the mor-
phology, but also the metabolism of the suspicious 
lesions. The pattern of accumulation of the marker 
in neoplastic lesions depends on various factors, 
such as the number of neoplastic cells, their meta-
bolic activity and the size of the lesion. PET-CT 
examination enables the localisation of the foci 
of pathological uptake of 18-fluorodeoxyglucose 
(FDG) in the metabolic image of an organism (vi-
sual qualitative assessment), and the quantitative 
assessment of glucose uptake measured with SUV 
(standard uptake value). The value of SUVmax gives 
information about maximum FDG uptake in the 
tumour area. This parameter is the most frequently 
used in clinical interpretation. It is commonly 
assumed that SUVmax > 2.5 is a positive result that 
signifies malignancy.
However, many authors recommend, apart 
from assessment of SUVmax, visual assessment of 
lesions, particularly nodules of small diameter 
and those with suspected neoplastic aetiology, 
despite little marker uptake [1].
However, increased 18F-FDG uptake may also 
concern non-neoplastic inflammatory lesions, 
which is connected with excessive activity of 
macrophages and neutrophils in the tissues [2].
The objective of the study was to assess the 
usefulness of PET-CT in the evaluation of solitary 
pulmonary lesions.
Material and methods
Among the patients referred for the PET-CT 
examination from the National Institute of Tu-
berculosis and Lung Diseases in the period from 
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January 2008 to May 2011, two groups were dis-
tinguished: patients with confirmed lung cancer, 
examined due to staging procedures; and patients 
with pulmonary lesions of ambiguous nature. 
In the present paper, only the patients from the 
second group were analysed.
The study group included 82 patients: 51 
men and 31 women, mean age 63.2 years (42–85 
years).
In the case of malignant lesions, histologi-
cal or cytological examinations of the material 
obtained from bronchoscopy, mediastinoscopy, 
transthoracic biopsy and/or intraoperatively were 
the reference tests.
In the case of benign lesions, negative results 
of histological and cytological examinations 
were the reference tests, or when biopsy was not 
performed, the results of long-term observation 
showing inflammatory character of lesions (in the 
case of their complete regression).
PET-CT examinations were performed in 
two centres: Euromedic in Warsaw (A-aparat GE 
Discovery STE) and the Department of Nuclear 
Medicine of the Medical University of Warsaw 
(B- Siemens Biograph Truepoint64). In all PET-
CT examinations, the radiopharmaceutical 18FDG 
was used, which was administered intravenously. 
In the 18FDG PET-CT examination, SUVmax for 
tumours was assessed. As a limit value for lesions 
suspected of neoplastic nature, SUVmax higher 
than 2.5 was assumed. 
All patients included in the study underwent 
single-phase helical computed tomography (CT) 
after contrast administration. Chest CT was 
performed at the National Institute of Tuber-
culosis and Lung Diseases, with the help of 
a Siemens SOMATOM Sensation 16 CT scan-
ner. The size of the lesions was determined based 
on CT, relying on a larger measurement.
A diagnostic value of PET-CT SUVmax > 2.5 
in the prognosis of malignant character of solitary 
pulmonary lesions was assessed. The results were 
expressed as follows: true positives (TP) — the 
number of patients with cancer and a positive 
result of the test, false positives (FP) — the num-
ber of patients without cancer and with a posi-
tive result of the test, false negatives (FN) — the 
number of patients with cancer and a negative 
result of the test, and true negatives (TN) — the 
number of patients without cancer and a negative 
result of the test. The test results were divided 
according to the parameters of a table including 
4 fields: TP, TN, FP and FN. Then, in order to 
assess diagnostic efficacy, the following parame-
ters were calculated: sensitivity (Se), specificity 
(Sp), accuracy (Acc), positive likelihood ratio 
(LR+), negative likelihood ratio (LR-) and diag-
nostic odds ratio (DOR), with 95% of confidence 
intervals. In order to estimate differences in the 
diagnostic efficacy of the tests, the sign test was 
applied. To conduct statistical tests, the program 
Statistica for Windows 6.5 was used.
Results
Malignant lesions
The presence of lung cancer on PET-CT was 
confirmed in 40 patients (48.8%). The group in-
cluded 30 men and 10 women; the mean age was 
65.9 years (51–85 years). Malignant lesions includ-
ed: 12 squamous cell carcinomas, 18 adenocarci-
nomas, 1 carcinoid and 9 non-small cell cancers 
(without precisely determined histological type).
The mean size of neoplastic lesions on chest 
CT was 27.9 (11–60 mm). All malignant lesions 
were of solid nature, apart from one that was not 
completely solid and turned out to be adenocar-
cinoma (lepidic type of adenocarcinoma).
In 38 patients from this group, SUVmax exceed-
ed 2.5 (TP results). The mean value of SUVmax was 
9.1 (1–26.8). A neoplastic lesion with high FDG 
PET-CT uptake is presented in Figure 1. 
The mean value of SUVmax in patients with 
adenocarcinoma was 8.8 (2–26.8). The mean 
value of SUVmax in patients with squamous cell 
carcinoma was 9.3 (2.9–16.3). The difference was 
not significant.
Based on SUVmax lower than 2.5, in 2 patients 
benign lesions were suspected, despite their neo-
plastic nature (FN results). Finally, in one of these 
cases carcinoid was diagnosed, and in the second, 
adenocarcinoma. In this case, the low value of 
SUVmax could have resulted from the small size 
of the nodule (11 mm).
Benign lesions 
Benign lesions were confirmed in 42 patients 
(51.2%): 21 men and 21 women. The mean age of 
patients in this group was 61 years (42-83 years). 
The size of lesions was determined based on chest 
CT in 29 patients. The mean size of lesions was 
21.7 mm (10-66 mm).
Thirty-seven patients had SUV max lower than 
or equal to 2.5. The SUVmax values were given in 
22 reports; in the remaining patients, the lesions 
did not accumulate the marker. The mean value 
of SUVmax for benign lesions was 1.9 (0.5-8.6). 
A benign lesion with low FDG PET-CT uptake is 
presented in Figure 2.
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Figure 1. Malignant mass localised in the right lung shows high 18F-FDG uptake on PET-CT image
Rycina 1. Zmiana ogniskowa w płucu prawym o charakterze złośliwym i wysokim gromadzeniu znacznika w PET-CT
Figure 2. Benign mass localised in the right lung shows little 18F-FDG uptake on PET-CT image 
Rycina 2. Zmiana ogniskowa w płucu prawym o charakterze łagodnym i słabym gromadzeniu znacznika w PET-CT
A B
A B
In four patients examined at the centre of 
the Medical University of Warsaw, SUVmax was 
measured additionally in the delayed phase. In 
the first phase, the mean value of SUVmax was 
2.2 (1–5.6). The second phase showed a slight 
increase in SUVmax in two patients, in one patient 
the value did not change, and in the last one 
SUVmax significantly decreased. In two patients 
in whom the SUVmax values increased in the 
second phase, inflammatory aetiology of lesions 
was confirmed.
Five patients with benign lesions had SUVmax 
higher than 2.5 (FP result). In three patients, 
inflammatory aetiology was confirmed histologi-
cally (in two cases intraoperatively). The final 
diagnosis was: sarcoidosis, granulomatosis with 
polyangiitis (GPA) and benign inflammatory 
lesion.
The diagnostic value of SUVmax greater than 
2.5 on PET-CT was assessed for the evaluation of 
the nature of the lesion (Figure 3). Test sensitivity 
was 95% (95% CI 84–99%), specifity — 88% (95% 
CI 75–95%), accuracy — 91.5% (95% CI 83–96%).
Positive predictive value (PPV) was 88.4%; 
thus the likelihood that the patient with the focus 
of increased 18F-FDG uptake had lung cancer 
was 88.4% (95% CI 76–95%). Negative predictive 
value (NPV) was 94.8%. Therefore, the likelihood 
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Figure 3. The diagnostic value of PET-CT SUVmax > 2.5 in the recog-
nition of malignant lung lesion (true positives — TP, true negatives 
— TN, false positives — FP, false negatives — FN)
Rycina 3. Wartość diagnostyczna SUVmax > 2.5 w badaniu PET-CT 
w prognozowaniu nowotworowego charakteru zmiany ogniskowej 
(wyniki prawdziwie dodatnie — TP, prawdziwie ujemne — TN, fałszy-
wie dodatnie — FP, fałszywie ujemne — FN)
that lung cancer did not occur in the patient 
without excessive 18F-FDG uptake was 94.8% 
(95% CI 83–99%).
Discussion
In the study group of 82 patients with solitary 
pulmonary lesions, a high sensitivity of PET-CT 
for predicting neoplastic character of lesion was 
found (95%), with a relatively lower specifity 
(88%). Among the studies that evaluate the value 
of PET-CT in diagnosis of pulmonary lesions, the 
most interesting are the meta-analysis by Gould 
et al. [3] and the study by Imdahl et al. [4]. The 
authors of the first publication proved that PET-
CT has a high sensitivity, with a relatively lower 
specifity for the evaluation of pulmonary lesions 
larger than 10 mm; however, its diagnostic value 
for lesions smaller than 10 mm is limited. Similar-
ly, the authors of the second publication showed a 
greater role of PET-CT in diagnosis of lesions larg-
er than 10 mm, but also a greater role of PET-CT 
in the evaluation of neoplastic foci of low grade. 
In the present study, the diameter of the smallest 
lesion was 11 mm, and the average diameter of 
benign and malignant lesions exceeded 20 mm.
The differences in the diagnostic value of 
PET-CT described in various research projects 
may depend on the type of benign lesions exami-
ned at PET-CT. The lower specificity of PET-CT 
in the study by Deppen et al. (sensitivity 89%, 
specificity 40%) was caused by the fact that many 
examined patients had pulmonary granulomas, 
which increased the number of false positive re-
sults [5]. Nomori et al. showed lower sensitivity of 
PET-CT (38%) because their study also concerned 
ground-glass opacity lesions (established on 
computed tomography), which corresponded to 
neoplastic foci with little marker uptake [6]. In the 
study group, only one lesion was not completely 
solid (it turned out to be a well differentiated 
adenocarcinoma) and it showed a low (although 
exceeding the cut off point of 2.5) SUVmax value.
Many studies concern the methodology of 
the evaluation of lesions in PET-CT. Lowe et al. 
found that SUV values and visual evaluation of 
the lesion are comparably precise in differenti-
ating between a benign and malignant lesion [7].
However, other researchers showed that 
having an SUV value of 2.5 assumed as the cut off value 
gives lower sensitivity than visual evaluation [8]. 
The SUV values depend on many factors, e.g. 
body mass (including fat tissue content, which 
accumulates less marker) [9, 10], blood glucose 
level (hyperglycaemia may cause increased mark-
er uptake and may lead to unreliable results) 
[11, 12], the time of the examination in relation 
to administration of the marker [13, 14] and the 
size of lesion [15, 16]. Due to the presented limita-
tions, while describing the lesion it is important 
to take into consideration both visual evaluation 
and SUVmax on PET-CT, and the morphology of 
the lesion on computed tomography.
In the study group, in 5 cases, high 18F-FDG 
uptake was found in patients with non-neoplas-
tic lesions in the course of sarcoidosis, GPA and 
unspecific inflammatory lesions.
Non-neoplastic lesions that show excessive 
18F-FDG uptake are lesions with a great amount of 
macrophages and lymphocytes, such as tubercu-
losis, other granulomas (sarcoidosis), pneumoco-
niosis, lung abscess and mycotic infections (with 
a lack of uptake in their necrotic part). Increased 
marker uptake may also occur in rare benign le-
sions, such as calcified haematoma, leiomyoma 
or inflammatory pseudotumour [2].
Patients with an inflammatory process in 
the lungs, who are frequently encountered in 
everyday practice, require special attention. 
One female patient from the study group had 
a pulmonary lesion which enlarged in follow-up 
examination after 6 months. It showed excessive 
18F-FDG uptake on PET-CT (SUVmax 5.3). During 
intraoperative examination, an inflammatory 
nature of the lesion was found (Fig. 4).
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Figure 4. Inflammatory pseudotumour. A — pulmonary window, axial image of CT scan shows nodule localised in the right upper lobe; B — after 
6 months, the nodule in the right upper lobe enlarged; C, D — increased 18F-FDG uptake is seen on PET-CT, suggesting neoplastic origin. Lesion 
was resected and pathology revealed an inflammatory pseudotumour
Rycina 4. Pseudoguz zapalny. A — okna płucne, przekrój osiowy, tomografia komputerowa uwidaczniają zmianę ogniskową w płacie górnym 
prawym; B — po 6 miesiącach zmiana ogniskowa w płacie górnym prawym powiększyła się; C, D — wzmożone gromadzenie znacznika w obrębie 
zmiany ogniskowej w płucu sugeruje jej nowotworowy charakter. Zmiana została usunięta, rozpoznano pseudoguz zapalny
The patients who underwent delayed phase 
of PET-CT require a separate discussion. In two 
out of four patients an increase of 18F-FDG up-
take was found in the delayed phase. Finally, the 
lesions were classified as benign. This does not 
confirm findings from the literature, i.e. that in the 
delayed phase, in proliferative lesions, increased 
marker uptake is noted.
In two patients with nodules of neoplastic 
nature, false negative result of PET-CT (SUVmax < 
2.5) was revealed. In one case, adenocarcinoma 
of 11 mm in diameter was finally diagnosed, and 
in another one — carcinoid.
In the literature there are reports on negative 
results of PET-CT in the case of lesions located 
in the lumen of the bronchus, or ground-glass 
opacities or not completely solid lesions. PET-CT 
may be particularly unreliable in the case of 
well differentiated adenocarcinomas of small 
size. The lowest 18F-FDG uptake is observed in 
adenocarcinomas with lepidic growth [17]. It 
is an invasive lung adenocarcinoma which ac-
counts for 3% of all lung cancers. In the majority 
of patients, radiological changes are discovered 
accidentally. On CT scans this type of tumour is 
often described as a ground-glass opacity or as 
a disseminated form of lesion [18]. The sensitivity 
of PET-CT may be slightly higher in nodules with 
a diameter exceeding 8–9 mm and predominating 
solid component.
Another lung neoplasm which is difficult to 
diagnose on PET-CT is carcinoid. Due to high dif-
ferentiation of cells, a typical carcinoid does not 
show excessive marker uptake [19]. Carcinoids 
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are distinguished by increased expression of so-
matostatin receptors; therefore, PET-CT that uses 
radiolabelled somatostatin analogues (68Ga-DO- 
-TATOC, 68Ga-DOTATATE) has a significantly 
higher sensitivity and specificity. Carcinoid was 
confirmed in one patient from the study group. 
The lesion was closing the right upper bronchus, 
but it did not show excessive 18F-FDG uptake on 
PET-CT  (Fig. 5).
Conclusions
In the examined material, high sensitivi-
ty (95%) and slightly lower specifity (88%) of 
PET-CT in diagnosis of the neoplastic nature 
of solitary pulmonary lesions was found. False 
negative results (2 cases) concerned patients with 
adenocarcinoma of small diameter (11 mm) and 
with carcinoid. False positive results (5 cases) 
concerned patients with sarcoidosis, granuloma-
tosis with polyangiitis and benign inflammatory 
A B
C D
Figure 5. Carcinoid of the right upper bronchus. A, B — lung and mediastinal window of enhanced CT scan show a mass in the right upper lobe; 
C, D — mass shows little 18F-FDG uptake on PET-CT image
Rycina 5. Rakowiak wychodzący z oskrzela górnopłatowego prawego. A, B — okna płucne i śródpiersiowe uwidaczniają masę w płacie górnym 
prawym. C, D — niskie gromadzenie znacznika w masie guza w badaniu PET-CT
lesions. In the authors’ opinion, while analysing 
the PET-CT examination, in the case of solitary 
lesions, it is vital to take into account numerous 
additional parameters: clinical data and the 
results of various imaging tests (with their retro-
spective evaluation). 
Conflict of interest
The authors declare no conflict of interest.
References
1. Herder G., Golding R., Hoekstra O. et al. The performance of 
18 fluorodeoxyglucose positron emission tomography in small 
solitary pulmonary nodules. Eur. J. Nucl. Med. Mol. Imaging. 
2004; 31: 1231–1236.
2. Bakheet S., Saleem M., Powel J., Al-Amro A., Larsson S., 
Mahassin Z. F-18 fluorodeoxyglucose chest uptake in lung 
inflammation and infection. Clin. Nucl. Med 2000; 25: 
273–278.
3. Gould M., Maclean C., Kuschner W., Rydzak C., Owens D. 
Accuracy of positron emission tomography for diagnosis of 
pulmonary nodules and mass lesions: a meta-analysis. JAMA 
2001; 285: 914–924.
Lucyna Opoka et al., Accuracy of FDG PET/CT in the evaluation of solitary pulmonary lesions
205www.pneumonologia.viamedica.pl
4. Imdahl A., Jenkner S., Brink I. et al. Validation of FDG posi-
tron emission tomography for differentiation of unknown pul-
monary lesions. European Journal of Cardio-thoracic Surgery 
2001; 20: 324–329.
5. Deppen S., Putnam J., Andrade G. et al. Accuracy of FDG-PET 
to diagnose lung cancer in a region of endemic granulomatous 
disease. Ann. Thorac. Surg. 2011; 9: 428–433.
6. Nomori H., Kosaka N., Watanabe K. et al. 11C-Acetate Positron 
Emission Tomography Imaging for Lung Adenocarcinoma 1to 
3 cm in Size With Ground-Glass Opacity Images on Computed 
Tomography Ann. Thorac. Surg. 2005; 80: 2020–2025.
7. Lowe V., Hoffman J., DeLong D., Patz E., Coleman R. Semi-
quantitative and visual analysis of FDG-PET images in pulmo-
nary abnormalities. J. Nucl. Med. 1994; 35: 1771–1776.
8. Al-Sugair A., Coleman R. Applications of PET in lung cancer. 
Semin. Nucl. Med. 1998; 28: 303–319.
9. Zasadny K., Wahl R. Standarized uptake values of normal 
tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-Dglucose: 
variations with body weight and a method for correction. 
Radiology 1993; 189: 847–850.
10. Kim C., Gupta N. Dependency of standardized uptake values 
of fluorine-18 fluorodeoxyglucose on body size: comparison of 
body surface area correction and lean body mass correction. 
Nucl. Med. Commun. 1996; 17: 890–894.
11. Lindholm P., Minn H., Leskinen-Kallio S., Bergman J., Ruotsalain-
en U., Joensuu H. Influence of the blood glucose concentration on 
FDG uptake in cancer: a PET study. J. Nucl. Med. 1993; 34: 1–6.
12. Langen K., Braun U., Rota Kops E. et al. The influence of plas-
ma glucose levels of fluorine-18-fluorodeoxyglucose uptake in 
bronchial carcinomas. J. Nucl. Med. 1993; 34: 355–359.
13. Hamberg L., Hunter G., Alpert N., Choi N., Babich J., Fischman A. 
The dose uptake ratio as an index of glucose metabolizm: 
useful parameter or oversimplification? J. Nucl. Med. 1994; 
35: 1308–1312.
14. Cremerius U., Fabry U., Neuerburg J., Zimny M., Osieka R., 
Buell U. Positron emission tomography with 18F-FDG to detect 
residual disease after therapy for malignant lymphoma. Nucl. 
Med. Commun. 1998; 19: 1055–1063.
15. Menda Y., Bushnell D., Madsen M., McLaughlin K., Kahn D., 
Kernstine K. Evaluation of various corrections to the standard-
ized uptake value for diagnosis of pulmonary malignancy. 
Nucl. Med. Commun. 2001; 22: 1077–1081.
16. Zielonka T., Pietrzykowski J., Wardyn K.PET-CT in evaluation 
of pulmonary nodule--case report. Pol Merk Lek. 2009; 158: 
119–22.
17. Marom E.,Sarvis S., Herdon J.,Patz E. T1 lung cancers: sen-
sitivity of diagnosis with fluorodeoxyglucose PET. Radiology 
2002; 223: 453–459.
18. Lis A., Zalewska A., Nykiel-Nalepa E. i wsp. Rak oskrzeli-
kowo-pęcherzykowy u osób młodych. Onkologia 2002; 6: 
391–394.
19. Erasmus J., McAdams H., Patz E. Jr. Coleman R., Ahuja V., 
Goodman P. Evaluation of primary pulmonary carcinoid tu-
mors using FDG PET. Am. J. Roentgenol 1998; 170: 1369–1373.
